We are live on ! Find out more
NVO

Novo Nordisk
NVO

564 hedge funds and large institutions have $8.88B invested in Novo Nordisk in 2019 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 179 increasing their positions, 211 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more call options, than puts

Call options by funds: $79.2M | Put options by funds: $47.1M

20% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 46

13% more funds holding in top 10

Funds holding in top 10: 8 → 9 (+1)

1% more funds holding

Funds holding: 559 → 564 (+5)

0% less capital invested

Capital invested by funds: $8.89B → $8.88B (-$10.8M)

0.2% less ownership

Funds ownership: 18.73% → 18.53% (-0.2%)

15% less repeat investments, than reductions

Existing positions increased: 179 | Existing positions reduced: 211

Holders
564
Holders Change
+5
Holders Change %
+0.89%
% of All Funds
12.37%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.2%
New
55
Increased
179
Reduced
211
Closed
46
Calls
$79.2M
Puts
$47.1M
Net Calls
+$32.1M
Net Calls Change
+$335K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$115M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$37.6M
3
CCM
Camber Capital Management
Massachusetts
+$35.4M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$33.2M
5
Capital International Investors
Capital International Investors
California
+$26.3M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$83.1M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$49.7M
3
USAA
United Services Automobile Association
Texas
-$49.6M
4
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
-$37.4M
5
AAMU
Amundi Asset Management US
Massachusetts
-$36.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
HWA
601
Heritage Wealth Advisors
Virginia
– -$16.3K -640 Closed
NCM
602
Next Capital Management
New York
– -$9K -344 Closed
W
603
WealthStone
Ohio
– -$7.5K -294 Closed
SIS
604
Sound Income Strategies
Florida
– -$7K -262 Closed
RCG
605
Ruggie Capital Group
Florida
– -$4K -140 Closed
CQS
606
Credential Qtrade Securities
– -$2.96K -116 Closed
CS
607
Candriam SCA
Luxembourg
– -$2.14M -84 Closed
OSAM
608
O'Shaughnessy Asset Management
Connecticut
– +$152 +6 +150%
PWMG
609
Prestige Wealth Management Group
New Jersey
– +$253 +10 New
21 22 23 24
25

NVO Hedge Fund Activity: Q3 2019 in Review

564 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q3 2019, worth a combined $8.88B — down 0.12% from $8.89B a quarter earlier.

Buyers outnumbered sellers: 55 funds opened new NVO positions and 46 closed out — a net gain of 9 holders — while 179 added to existing stakes and 211 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $115M. The largest seller was BlackRock, cutting an estimated $83.1M.

  • 564 institutional investors held Novo Nordisk (NVO) as of Q3 2019, up from 559 in Q2 2019.
  • Funds reported $8.88B of Novo Nordisk stock for Q3 2019, down 0.12% quarter-over-quarter.
  • 55 funds opened new Novo Nordisk positions in Q3 2019 and 46 closed out, a net change of +9 holders.
  • The largest Novo Nordisk buyer in Q3 2019 was Renaissance Technologies, an estimated $115M added.
  • The largest Novo Nordisk seller in Q3 2019 was BlackRock, an estimated $83.1M sold.

Based on aggregated 13F filings for Q3 2019.